• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Cardiovascular

AstraZeneca is pleased to present healthcare professionals with a variety of cardiovascular resources for your informational purposes.The educational materials are intended to provide disease-state information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

May 21 - 24, 2022

Heart Failure Association of the European Society of Cardiology (ESC-HFA) 2022

Explore AstraZeneca Scientific Materials Visit Congress Site

April 2-4, 2022

American College of Cardiology (ACC) 2022 Annual Meeting

Explore AstraZeneca Scientific Materials Visit Congress Site

November 4-7, 2021

American Society of Nephrology (ASN) - Kidney Week 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

August 27-30, 2021

European Society of Cardiology (ESC) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site

May 15-17, 2021

American College of Cardiology (ACC) 2021

Explore AstraZeneca Scientific Materials Visit Congress Site
  • BRILINTA® (ticagrelor) Tablets
  • CRESTOR® (rosuvastatin calcium) Tablets
  • EPANOVA® (omega-3 carboxylic acids) Capsules
  • FARXIGA® (dapagliflozin) Tablets

Email Recepient

  1. Colleague
  2. Myself

e-Learning

Web Enduring Program SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice

HFSA Learning Portal

29-Oct-2021 to 29-Oct-2022

Enduring Material on the HFSA’s Online Learning Center for 12-calendar months

Learn More

e-Learning

Enduring Material for THT 2022

Cardiovascular Research Foundation

01-Feb-2021 to 02-Feb-2023

Enduring Material for THT 2022 available on demand for 1 year after the program

Learn More

e-Learning

TCT 2021

Cardiovascular Research Foundation

4-Nov-2021 to 06-Nov-2022

TCT videos will be available on-demand for one year after the program

Learn More

e-Learning

AHA Scientific Sessions 2021

American Heart Association, Inc.

13-Nov-2021 to 31-Dec-2022

Acute Coronary Syndrome Program Track

Learn More

e-learning

American Heart Association (AHA) Scientific Sessions 2021

American Heart Association, Inc.

13-Nov-2021 to 31-Dec-2022

Heart Failure Program Track

Learn More

e-Learning

Live Streamed - The Conundrum of Managing Chronic Coronary Disease: DPI or DAPT?

AcademicCME, LLC.

04-Nov-2021 to 19-Dec-2022

Live and Live-Streamed Satellite Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) 2021

Learn More

podcast

Web Enduring - The Conundrum of Managing Chronic Coronary Disease: DPI or DAPT?

AcademicCME, LLC.

20-Dec-2021 to 19-Dec-2022

Enduring On-demand Webcast developed from the Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) 2021

Learn More

podcast

UPDATES IN SECONDARY PREVENTION OF ISCHEMIC STROKE AND TRANSIENT ISCHEMIC ATTACK

AcademicCME, LLC.

15-Nov-2021 to 14-Nov-2022

On-demand webcast Delivering of Advanced Education for Neurologists and Other Vascular Medicine Clinicians

Learn More

e-Learning

Enduring Material - Antiplatelet Therapy in Patients with Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack

Voxmedia LLC

30-Nov-2021 to 30-Nov-2022

AHA Enduring Material

Learn More

e-Learning

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

Voxmedia LLC

05-Nov-2021 to 30-Nov-2022

TCT Enduring Material

Learn More

e-Learning

Incorporating SGLT2 Inhibitors into Clinical Practice for Cardiovascular and Renal Risk Reduction

Voxmedia LLC

13-Jan-2022 to 13-Jan-2023

Online enduring material for 12 months

Learn More

podcast

Getting It Right the First Time: Antiplatelet Therapy for Secondary Stroke Prevention- 2021 Hospital Medicine Summit

Integrity Continuing Education, Inc.

15-Nov-2021 to 15-Nov-2022

On-demand Webcast

Learn More

e-Learning

Insights into Using Dual Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack

Voxmedia LLC

20-Oct-2021 to 20-Oct-2022

Enduring material from the 2021 American Neurological Association Virtual CME Symposium

Learn More

e-Learning

Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?

Medical Learning Institute Inc

10-Feb-2022 to 09-Mar-2023

• A 1.5 credit hour online enduring activity (PeerView onDemand)

• Point-of-care practice tools

Learn More

Redirecting...

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice